Skip to main content

Table 2 Experimental studies on selected CM prescriptions in diabetes nephropathy management

From: Chinese medicines in the treatment of experimental diabetic nephropathy

CM preparations

DN model

Nephro-protective mechanisms

Pharmacodynamic indicators

Dosage

Duration

Ref.

Xiao-chai-hu-tang

STZ rat

↓TGF-β1, FN, and collagen IV,↑BMP-7, SOD

FBG, BUN, SCr, renal hypertrophy

200 mg/kg b.w

4 weeks

[100]

LiuweiDihuang Decoction

STZ rat

↓MDA, iNOS, tNOS, cNOS, ET-1, ET(A), ↑NO, MMP-2, MMP-9, GSH-Px, SOD

FBG, plasma insulin level

5, 10, or 15 g/kg b.w

4 weeks

[57]

Tangshenling mixture plus benazepril

STZ rat

↓ANF, GLUT1

UAE, CCr, K/B ratio

5 g/kg b.w

6 weeks

[71]

DangguiBuxue Tang

STZ rat

↓TGF-β1

K/B ratio, UAE, β(2)-MG concentrations, CCr, FBG, TC, TG

–

8 weeks

[69]

Dang-gui and Huang-qi mixture

STZ rat

↓TGF-β1, Ang II

FBG, TG, CHO, HDL, SCr, CCr, BUN, β(2)-MG,K/B ratio, GA

–

8 weeks

[68]

Tangshenning Recipe

STZ rat

↓TXB(2), TXB(2)/6-keto-PGF1 α, CGRP, MDA; ↑ET, SOD, GSH

–

35 g/kg b.w

8 weeks

[101]

Shenbao Recipe

STZ rat

↓CTGF, ↑MMP-9

UAlb, FBG, TC, SCr

13 g/kg b.w

8 weeks

[102]

Wu-ling-san

STZ rat

↓NF-κB, TGF-β1, FN, AGEs, mitochondrial TBARS, CML

UAE, UAlb, CCr, mesangial matrix expansion

2.5 g/kg b.w

10 weeks

[103]

Zhen-wu-tang

STZ rat

↓Ang II, ↑nephrin, podocin

Body weight, polyurea, UAE, SCr, BUN

320 mg/kg b.w.

12 weeks

[72]

FufangXueshuantong Capsule

HFD + STZ rat

↑GSH-px, SOD

UAE, CCr, masengial matrix expansion

450, 900, or 1800 mg/kg b.w

12 weeks

[104]

Hachimi-jio-gan

STZ rat

↓AGEs, sorbitol

FBG, UAE, CCr, serum glycosylated protein, BUN, serum albumin level, TG, TC

50,100, or 200 mg/kg b.w

15 weeks

[59]

Kangen-karyu

STZ mouse

↓AGEs, TGF-β1, collagen IV

FBG, BUN

100, 200 mg/kg b.w

18 weeks

[58]

Hachimi-jio-gan

OLETF rats

↓NF-κB, TGF-β1, FN, iNOS, cyclooxygenase-2, AGEs, TBARS

UAE, CCr, FBG

50, 100, or 200 mg/kg b.w

32 weeks

[61]

Yiqiyangyinhuayutongluo recipe

HFD + STZ rat

↑Nephrin

FBG, UAE, 24 h U-nephrin

0.8 g/kg b.w

32 weeks

[105]

  1. AGEs advanced glycation end products, ANF atrial natriuretic factor, Ang II angiotensin II, BMP bone morphogenetic protein, BUN blood urea nitrogen, CCr creatinine clearance rate, CHO cholesterol, CML N(epsilon)-(carboxymethyl)lysine, CGRP calcitonin gene-related peptide, CTGF connective tissue growth factor, ET endothelin, FBG fasting blood glucose, GA glomerular area, GLUT glucose transporter, TGF transforming growth factor, FN fibronectin, GSH-Px glutathione peroxidase, HDL high density lipoprotein, HFD high fat diet, K/B kidney/body weight, NF-κB nuclear factor κB, NO nitric oxide, cNOS constitutive nitric oxide synthase, eNOS endothelial nitric oxide synthase, iNOS inducible nitric oxide synthase, nNOS constitutive nitric oxide synthase, tNOS total nitric oxide synthase, MDA malondialdehyde, MMP matrix metalloproteinase, β (2)-MG Urine β (2)-microglobin, OLETF otsuka long-Evans Tokushima Fatty, PGF prostaglandin F, SCr serum creatinine clearance rate, STZ streptozotocin, SOD superoxide dismutase, TGF transforming growth factor, TG triglyceride, TC total cholesterol, TARS thiobarbituric acid reactive substances, TXB(2) thromboxane B 2, UAE urinary albumin excretion rate, UAlb urinary microalbumin